Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nebulized Bupivacaine Analgesia for Cleft Palate Repair
Sponsor: Assiut University
Summary
In this study we introduce a potent local anesthetic; bupivacaine 0.5% in 0.5 mg/kg dose by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.
Official title: Preemptive Nebulized Bupivacaine for Pain Control After Cleft Palate Repair in Children: A Randomized Double Blind Controlled Trial
Key Details
Gender
All
Age Range
1 Year - 7 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2021-06-14
Completion Date
2026-09-20
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
Bupivacaine Hydrochloride
Preoperative Nebulized Bupivacaine 0.50% 0.50 mg.kg-1
0.9% saline
Preoperative nebulized same volume of saline placebo
Locations (1)
Assiut university hospital
Asyut, Assuit, Egypt